New “slow flower” farms grow beautiful blooms—without health-harming chemicals used by overseas operations that dominate the ...
The achievement of the first sales milestone already in the second year of commercialization is a testament of the commercial capability of our partner AKP in this important market. The strong sales ...
fumigatus has important implications for the scope of clinical antifungal stewardship. Given the human health consequences of disease caused by azole-resistant Aspergillus, it is hardly surprising ...
Chromated arsenicals are a group of pesticides that protect wood against termites, fungi and other pests that can degrade or threaten the integrity of wood products, and the Environmental Protection ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...
For Cresemba, this comprises a milestone payment for sales in Canada, by AVIR Pharma Inc, as well as the first sales milestone payment for the Middle East and North Africa (MENA) region, by Hikma ...
Second, there is a greater chance of drug interactions. Azole antifungals (e.g., fluconazole, itraconazole and voriconazole) alter metabolism of cyclophosphamide, a cytotoxic agent, through ...
the Company’s second-generation triterpenoid antifungal in development for the treatment of severe invasive fungal infections. “We are pleased to advance our potent, second SCYNEXIS ( NASDAQ ...
Azole Therapy: A class of antifungal medications used to treat fungal infections, including those caused by invasive fungi. This Nature Research Intelligence Topic summary is one of 30,000 created ...
Basilea Pharmaceutica Ltd announced that its antifungal drug, Cresemba® (isavuconazole), surpassed sales targets in Japan, triggering a CHF 1.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results